|
|
|
|
|
Sponsored by: |
Janssen, LP |
Information provided by: | NIH AIDS Clinical Trials Information Service |
ClinicalTrials.gov Identifier: | NCT00002132 |
To evaluate the safety and efficacy of itraconazole oral solution versus fluconazole tablets for the treatment of esophageal candidiasis in immunocompromised patients.
Condition | Intervention |
Candidiasis, Esophageal HIV Infections |
Drug: Itraconazole Drug: Fluconazole |
MedlinePlus related topics: | AIDS Esophagus Disorders Yeast Infections |
ChemIDplus related topics: | Fluconazole Itraconazole |
Study Type: | Interventional |
Study Design: | Treatment, Double-Blind, Safety Study |
Official Title: | Randomized, Controlled, Double-Blind Study of Itraconazole Oral Solution Versus Fluconazole Tablets for the Treatment of Esophageal Candidiasis. |
Ages Eligible for Study: | 13 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria
Patients must have:
Exclusion Criteria
Co-existing Condition:
Patients with the following symptoms or conditions are excluded:
Concurrent Medication:
Excluded:
Patients with the following prior conditions are excluded:
Prior Medication:
Excluded:
United States, Arizona | |||||
Dr Eskild A Petersen | |||||
Tucson, Arizona, United States, 85724 | |||||
United States, California | |||||
UCSD Med Ctr | |||||
San Diego, California, United States, 92103 | |||||
Los Angeles County - USC Med Ctr | |||||
Los Angeles, California, United States, 90033 | |||||
United States, District of Columbia | |||||
George Washington Univ Med Ctr | |||||
Washington, District of Columbia, United States, 20037 | |||||
United States, Georgia | |||||
Emory Univ School of Medicine | |||||
Atlanta, Georgia, United States, 30303 | |||||
United States, Illinois | |||||
Rush Presbyterian - Saint Luke's Med Ctr | |||||
Chicago, Illinois, United States, 60612 | |||||
United States, Maryland | |||||
Johns Hopkins Univ School of Medicine | |||||
Baltimore, Maryland, United States, 21205 | |||||
United States, Michigan | |||||
Wayne State Univ / Harper Hosp | |||||
Detroit, Michigan, United States, 48201 | |||||
United States, Missouri | |||||
Univ of Missouri at Kansas City School of Medicine | |||||
Kansas City, Missouri, United States, 64108 | |||||
Infectious Diseases Association / Research Med Ctr | |||||
Kansas City, Missouri, United States, 64132 | |||||
United States, New York | |||||
Montefiore Med Ctr | |||||
Bronx, New York, United States, 10467 | |||||
Dr Douglas Dieterich | |||||
New York, New York, United States, 10016 | |||||
Erie County Med Ctr | |||||
Buffalo, New York, United States, 14215 | |||||
United States, North Carolina | |||||
Univ of North Carolina | |||||
Chapel Hill, North Carolina, United States, 27599 | |||||
Bowman Gray School of Medicine | |||||
Winston Salem, North Carolina, United States, 27157 | |||||
United States, Ohio | |||||
Univ Hosps of Cleveland | |||||
Cleveland, Ohio, United States, 44106 | |||||
United States, Texas | |||||
Austin Infectious Disease Consultants | |||||
Austin, Texas, United States, 78705 | |||||
Houston Veterans Administration Med Ctr | |||||
Houston, Texas, United States, 77030 |
Janssen, LP |
Study ID Numbers: | 236A, ITR-USA-12 |
First Received: | November 2, 1999 |
Last Updated: | June 23, 2005 |
ClinicalTrials.gov Identifier: | NCT00002132 |
Health Authority: | United States: Food and Drug Administration |
|
|
|
|
|